Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study.
Saved in:
| Title: | Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study. |
|---|---|
| Authors: | Xie SH; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China., Yang LT; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.; Department of Thoracic Surgery, Baoji Traditional Chinese Medicine Hospital, Baoji, Shaanxi, China., Zhang H; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.; Department of Thoracic Surgery, Gaozhou People's Hospital, Gaozhou, Guangdong, China., Tang ZL; Department of Thoracic Surgery, Quanzhou First Hospital, Quanzhou, Fujian, China.; Department of Thoracic Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China., Lin ZW; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China., Chen Y; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China., Hong ZN; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian, China.; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, China., Xu RY; Department of Thoracic Surgery, Quanzhou First Hospital, Quanzhou, Fujian, China.; Department of Thoracic Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China., Lin WL; Department of Thoracic Surgery, Gaozhou People's Hospital, Gaozhou, Guangdong, China., Kang MQ; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian, China.; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, China. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Feb 05; Vol. 15, pp. 1332492. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024). |
| Publication Type: | Multicenter Study; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38375480 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xie+SH%22">Xie SH</searchLink>; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Yang+LT%22">Yang LT</searchLink>; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.; Department of Thoracic Surgery, Baoji Traditional Chinese Medicine Hospital, Baoji, Shaanxi, China.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.; Department of Thoracic Surgery, Gaozhou People's Hospital, Gaozhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Tang+ZL%22">Tang ZL</searchLink>; Department of Thoracic Surgery, Quanzhou First Hospital, Quanzhou, Fujian, China.; Department of Thoracic Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Lin+ZW%22">Lin ZW</searchLink>; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Hong+ZN%22">Hong ZN</searchLink>; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian, China.; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Xu+RY%22">Xu RY</searchLink>; Department of Thoracic Surgery, Quanzhou First Hospital, Quanzhou, Fujian, China.; Department of Thoracic Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.<br /><searchLink fieldCode="AU" term="%22Lin+WL%22">Lin WL</searchLink>; Department of Thoracic Surgery, Gaozhou People's Hospital, Gaozhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Kang+MQ%22">Kang MQ</searchLink>; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian, China.; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Feb 05; Vol. 15, pp. 1332492. <i>Date of Electronic Publication: </i>2024 Feb 05 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Multicenter Study; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38375480 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1332492 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1332492 Titles: – TitleFull: Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xie SH – PersonEntity: Name: NameFull: Yang LT – PersonEntity: Name: NameFull: Zhang H – PersonEntity: Name: NameFull: Tang ZL – PersonEntity: Name: NameFull: Lin ZW – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Hong ZN – PersonEntity: Name: NameFull: Xu RY – PersonEntity: Name: NameFull: Lin WL – PersonEntity: Name: NameFull: Kang MQ IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 02 Text: 2024 Feb 05 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
